改良中心静脉导管胸腔闭式引流治疗癌性胸水的临床应用

Clinical Application of Improve Central Venous Catheterization Closed Thoracic Drainage for Treating Carcinous Hydrothorax

目的:比较改良中心静脉导管胸腔闭式引流后腔内注药和常规胸穿抽液后腔内注药两种方式治疗癌性胸水的疗效。方法:将78例癌性胸水患者随机分成两组,分别进行中心静脉导管闭式引流和常规胸腔穿刺,并均于胸腔内注入力尔凡。结果:引流腔内注药组46例中完全缓解22例,部分缓解19例,无效和进展5例。抽液腔内注药组32例中完全缓解11例,部分缓解7例,无效和进展14例。结论:应用改良中心静脉导管胸腔闭式引流癌性胸水操作安全、简便,能最大限度地排净胸水,对控制癌性胸水有较好的疗效。

Objective： To compare the efficacy of closed thoracic drainage between improve central venous catheterization and conventional pleural aspiration two different ways for treating carcinous hydrothorax. Methods：78 patients with carcinous hydrothorax were randomly assigned to central venous catheterization closed thoracic drainage group or routine way of pleuracentesis group. Lierfan was infused into the thoracic cavity in patients after drainage. Results： 22 of 46 patients with central venous catheterization were completely relaxed,19 patients were partly relaxed,14 patients were inefficacy and advanced. Conclusion：It＇s safe, effective,and convenient to treat carcinous hydrothorax with continuous drainage of improve central venous duct, and it can furthest exclude hydrothorax. There are preferable curative effects to control careinous hydrothorax.